nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—TDO2—Monoamine Transport—HRH3—narcolepsy	0.152	0.152	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—PENK—narcolepsy	0.0426	0.0426	CbGpPWpGaD
Tolmetin—TDO2—Monoamine Transport—TNF—narcolepsy	0.0327	0.0327	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0262	0.0262	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0262	0.0262	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0215	0.0215	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—narcolepsy	0.0193	0.0193	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—PENK—narcolepsy	0.0191	0.0191	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DQA1—narcolepsy	0.0184	0.0184	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0175	0.0175	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0175	0.0175	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DQB1—narcolepsy	0.0172	0.0172	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0169	0.0169	CbGpPWpGaD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—narcolepsy	0.0166	0.0166	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—TRH—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—PENK—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Tolmetin—MPO—IL23-mediated signaling events—TNF—narcolepsy	0.0153	0.0153	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CHKB—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0138	0.0138	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HCRTR2—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HCRTR1—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—HLA-DRB1—narcolepsy	0.0131	0.0131	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—P2RY11—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—HRH3—narcolepsy	0.012	0.012	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—NPS—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—narcolepsy	0.0118	0.0118	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HCRT—narcolepsy	0.011	0.011	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—narcolepsy	0.0107	0.0107	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PENK—narcolepsy	0.00978	0.00978	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—narcolepsy	0.00961	0.00961	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CPT1B—narcolepsy	0.0096	0.0096	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00958	0.00958	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.0089	0.0089	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—narcolepsy	0.00846	0.00846	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00833	0.00833	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—TRH—narcolepsy	0.00832	0.00832	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00793	0.00793	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00793	0.00793	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—narcolepsy	0.00764	0.00764	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HCRTR1—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HCRTR2—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—P2RY11—narcolepsy	0.00729	0.00729	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HRH3—narcolepsy	0.00729	0.00729	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HCRTR1—narcolepsy	0.00686	0.00686	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HCRTR2—narcolepsy	0.00686	0.00686	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00682	0.00682	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—P2RY11—narcolepsy	0.00662	0.00662	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HCRT—narcolepsy	0.0062	0.0062	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—narcolepsy	0.00617	0.00617	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—TAC1—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—NPS—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HCRT—narcolepsy	0.00563	0.00563	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PENK—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00541	0.00541	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.00503	0.00503	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PENK—narcolepsy	0.00502	0.00502	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00477	0.00477	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TRH—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00463	0.00463	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TRH—narcolepsy	0.00427	0.00427	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00417	0.00417	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HRH3—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HCRTR2—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HCRTR1—narcolepsy	0.00405	0.00405	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.00393	0.00393	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—P2RY11—narcolepsy	0.00391	0.00391	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HRH3—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00368	0.00368	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—HTR2A—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00358	0.00358	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—NPS—narcolepsy	0.00341	0.00341	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—TAC1—narcolepsy	0.00341	0.00341	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HCRT—narcolepsy	0.00333	0.00333	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—NPS—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—TAC1—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CHKB—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PENK—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TRH—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CHKB—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HRH3—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CPT1B—narcolepsy	0.00206	0.00206	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—HTR2A—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—HTR2A—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TAC1—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NPS—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CPT1B—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
